Prevalence of Hyperprolactinemia in Systemic Scleroderma
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hyperprolactinemia
- Scleroderma
- Sclerosis, Systemic
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04746313
- Collaborators
- Association pour la Formation et la Recherche en Médecine Interne (AFORMI)
- Investigators
- Principal Investigator: David Launay, MD,PhD University Hospital, Lille